Achiko
Achiko AG (SIX: ACHI.SW) is developing disruptive diagnostic solutions that puts people first. Invented by Dr Michael Edel, the company’s flagship product is a fast, friendly, affordable and accurate Covid-19 test with a companion app. The test and companion app were launched in Indonesia in mid-2021 and AptameX™ received the CE Mark in the European Union in May 2022. Achiko creates and develops aptamer-based diagnostics through its biotechnology division, AptameX™ and companion health apps via its digital mobile health technology division, Teman Sehat™. The AptameX™ DNA aptamer tests can be rapidly chemically synthesised, are cost-effective and have wide potential across multiple disease diagnostics. Leveraging AptameX™ and Teman Sehat™, Achiko aims to deliver fast, accurate and affordable diagnostic testing for a range of pathogenic diseases and therapeutic indications in the rapidly evolving healthcare diagnostics field. Headquartered in Zurich, Achiko has offices in Jakarta and Singapore.
7-day free trial · no credit card
Verified contacts
3
available on Kipplo
LinkedIn employees
9
11 to 50 range
Open roles
—
no listings
Distinct roles
3
indexed titles
Tech stack
2
tools in use
Monthly traffic
—
organic / mo
Sign up free to see all 3 verified contacts at Achiko
Free for 7 days · 50 credits · no card · only pay for verified records.
Decision-makers and verified team members
3 contacts with verified email or phone · masked until revealed.
No verified contacts on record for this company yet.
Top roles at Achiko
3 distinct titles indexed · top 3 shown.
- 1marketing officer
- 1petugas teman sehat
- 1product specialist
Sign up to unlock all 3 contacts at Achiko
Free for 7 days · 50 credits · no card · only pay for verified records.
Sign up to reveal 3 verified contacts at Achiko
7-day trial · no credit card · cancel anytime · only pay for verified records.
Trusted by sales, marketing, and GTM engineering teams.